Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

The majority of institutional investors believes alternatives are essential in their portfolios

Wednesday, September 26, 2012

Beverly Chandler, Opalesque London: The Natixis Global Asset Management survey of global institutional investors released today showed that alternative investments are featuring more often than not in their portfolios. The firm found that seven in 10 institutional investors believe it is essential to invest in alternative investments – such as hedge funds, private equity or venture capital – to diversify portfolio risk and nearly as many believe it is essential to invest in alternative assets to outperform the broad market.

Natixis surveyed 482 institutional investors from 13 countries around the world and the median asset level of survey respondents was in the region of $23bn. They found that of investors who already use alternative assets, more than eight in 10 say they are pleased with the performance of those holdings. The report says: "Looking forward, three in five investors say the alternative strategies they invest in will outperform last year’s returns".

Beyond that, a solid majority of investors who currently use alternatives would keep their allocation the same if they were starting over again. Among those who would change their allocation to those asset classes, twice as many would increase their allocation as would decrease it. U.K. investors, at 44%, were the most likely to say they would raise their allocation to alternative investm......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its